JPRN-UMIN000004365尚未招募1 期
Effect of aromatase inhibitor with LH-RH agonisit for tamoxifen resistant recurrent breast cancer - AI with LH-RH study
The University of Tokushima graduate school0 个研究点目标入组 50 人开始时间: 2010年10月12日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •male breast cancer
研究者
相似试验
招募中
3 期
Effect of Aromatase inhibitors combination with oral contraceptive pills versus GnRH agonist on uterine myomaterine Myoma.Leiomyoma of uterusIRCT20140820018866N7Tehran University of Medical Sciences42
招募中
2 期
Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial CancerEndometrial Neoplasm Malignant Stage INCT05247268Fudan University104
已完成
1 期
Comparing the effect of Aromatase inhibitor (Letrozol) + Cabergoline (Dostinex) and letrozol alone on uterine myoma regressioIRCT201506205283N12Vice chancellor for Research,Tabriz University Of Medical Sciences76
Unknown
不适用
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast CancerAdvanced Breast CancerNCT01311037King Faisal Specialist Hospital & Research Center2
进行中（未招募）
不适用
Phase II study of aromatase inhibitors in women with potentially hormone responsive recurrent/metastatic gynaecological neoplasmsWomen with oestrogen receptor and/or progesterone receptor positive (ER/PR+ve) potentially hormone responsive recurrent or metastatic gynaecological cancer including selected patients with epithelial ovarian cancer, endometrial cancers, miscellaneous sarcomas and sex cord stromal tumours of the ovaryEUCTR2011-003192-11-BEniversity of Sydney